Thiébaut R - Search Results

1

Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort.

Peuchant O, Capdepont S, Ragnaud JM, Aurillac-Lavignolle V, Thiébaut R, Fleury H, Masquelier B; ANRS CO3 Aquitaine Cohort. Peuchant O, et al. Among authors: thiebaut r. Antivir Ther. 2007;12(4):559-62. doi: 10.1177/135965350701200413. Antivir Ther. 2007. PMID: 17668565

2

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.

Thiébaut R, Daucourt V, Mercié P, Ekouévi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F. Thiébaut R, et al. Clin Infect Dis. 2000 Dec;31(6):1482-7. doi: 10.1086/317477. Epub 2000 Nov 29. Clin Infect Dis. 2000. PMID: 11096016

3

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

Le Moing V, Thiébaut R, Chêne G, Leport C, Cailleton V, Michelet C, Fleury H, Herson S, Raffi F; APROCO Study Group. Le Moing V, et al. Among authors: thiebaut r. J Infect Dis. 2002 Feb 15;185(4):471-80. doi: 10.1086/338929. Epub 2002 Jan 31. J Infect Dis. 2002. PMID: 11865399

4

Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.

Mercié P, Thiébaut R, Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, Lawson-Ayayi S, Roudaut R, Dabis F. Mercié P, et al. Among authors: thiebaut r. Ann Med. 2002;34(1):55-63. doi: 10.1080/078538902317338652. Ann Med. 2002. PMID: 12014436 Free article. Clinical Trial.

5

Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.

Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Thiébaut R, et al. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):380-6. doi: 10.1097/00126334-200307010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12843750

6

Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.

Thiébaut R, Pellegrin I, Chêne G, Viallard JF, Fleury H, Moreau JF, Pellegrin JL, Blanco P. Thiébaut R, et al. AIDS. 2005 Jan 3;19(1):53-61. doi: 10.1097/00002030-200501030-00006. AIDS. 2005. PMID: 15627033 Free article.

7

Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004.

Thiébaut R, Aurillac-Lavignolle V, Bonnet F, Ibrahim N, Cipriano C, Neau D, Dupon M, Dabis F, Mercié P; Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA). Thiébaut R, et al. AIDS. 2005 Apr 29;19(7):729-31. doi: 10.1097/01.aids.0000166097.46940.35. AIDS. 2005. PMID: 15821400

8

Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.

Pellegrin I, Thiébaut R, Blanco P, Viallard JF, Schrive MH, Merel P, Chêne G, Fleury H, Moreau JF, Pellegrin JL. Pellegrin I, et al. Among authors: thiebaut r. J Med Virol. 2005 Oct;77(2):164-72. doi: 10.1002/jmv.20452. J Med Virol. 2005. PMID: 16121362

9

Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.

Mercié P, Thiébaut R, Aurillac-Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Cipriano C, Neau D, Morlat P, Ragnaud JM, Dupon M, Bonnet F, Lawson-Ayayi S, Malvy D, Roudaut R, Dabis F; Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA). Mercié P, et al. Among authors: thiebaut r. HIV Med. 2005 Nov;6(6):380-7. doi: 10.1111/j.1468-1293.2005.00324.x. HIV Med. 2005. PMID: 16268819 Free article.

10

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group. Thiébaut R, et al. Antivir Ther. 2005;10(7):811-23. doi: 10.1177/135965350501000706. Antivir Ther. 2005. PMID: 16315369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters